KELLY REID: Open Payments
NPI 1033706981 · EAST LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,399 in 118 payments from 19 companies in 2025. Trend: 2023 $2,103 · 2024 $1,872 · 2025 $2,399
Food & beverage: $2,399
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 27 | $561 |
| Alkermes, Inc. | 15 | $383 |
| ABBVIE INC. | 20 | $308 |
| Axsome Therapeutics, Inc. | 7 | $176 |
| E.R. Squibb & Sons, L.L.C. | 8 | $165 |
| Vanda Pharmaceuticals Inc. | 7 | $137 |
| Janssen Pharmaceuticals, Inc | 5 | $122 |
| Neurocrine BioSciences, Inc. | 6 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $98 |
| Lundbeck LLC | 3 | $58 |
Products named: REXULTI, ARISTADA, VRAYLAR, ABILIFY MAINTENA, COBENFY, Auvelity, FANAPT, INGREZZA.
Industry payments across MI — which companies pay providers there.
